Satellos Bioscience Inc ICOTF

Primary Symbol: T.MSCL Alternate Symbol(s): MSCLF

Healthcare Biotechnology

Satellos Bioscience Inc. is a Canada-based biotechnology company. The Company is engaged in developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and disorders. The Company is focused on the research in muscle stem cell polarity into a proprietary discovery platform, called MyoReGenX, to identify degenerative muscle diseases where deficits in this process affect muscle regeneration and are amenable to therapeutic intervention. With this platform, the Company is building a pipeline of therapeutics to correct muscle stem cell polarity and promote the body’s innate muscle repair and regeneration process. The Company’s lead program is an oral, small molecule drug candidate in development as a potential disease-modifying treatment for Duchenne muscular dystrophy. It has wholly owned subsidiaries in Australia (Satellos Bioscience Australia Pty Ltd), in Canada (Amphotericin B Technologies, Inc.) and in Delaware, USA (Satellos Bioscience US, Inc.).

TSX:MSCL - Post by User

Satellos Bioscience Inc

Bullboard Posts

Post by trumpmasteron Mar 18, 2017 12:20pm

129 Views

Post# 25997554

Trap defense

With a bid of 2.9 million at .04 and a ask of 1.9 or more at .05 they have us trapped at this price range. As you saw on Monday though when they want shares they will buy it up. Approx 17 plus million gobbled up last week in one day.

As as far as value of company goes I think it's worth at least half of the milestone payments around 15 to 20 million dollars or .15 to .25 cents per share.

trump

Bullboard Posts

How does sponsorship affect share price?